TweetA working group from the United States recently made a series of recommendations for how medical and public health professionals should respond to a bioterror attack using botulinum toxin. Dr. Stephen S. Arnon and his colleagues from organizations such as … Read More

A new test to detect the presence of low levels of Botulinum toxin is currently being developed by Quanterix Corp. and the University of Massachusetts-Dartmouth. Read More

XOMA, LLC., was recently awarded a major federal contract to develop an antitoxin to treat human botulism toxin. Read More

Researchers from Australia have discovered a means of blocking the action of the potential bioweapon botulinum toxin, which may lead to ways to treat exposure. Read More

The Biomedical Advanced Research and Development Authority will exercise options under a botulism antitoxin supply contract with Cangene Corporation. Read More